The Epidemiology of Oral HPV Infection among a Multinational Sample of Healthy Men
Background: Oral human papillomavirus type-16 (HPV16) infection is a risk factor for oropharyngeal cancer. We examined oral HPV infection among healthy men. Methods: Oral rinse/gargle specimens and questionnaire data were collected from 1,688 healthy men aged 18 to 74 (median = 31 years), from the U...
Saved in:
Published in | Cancer epidemiology, biomarkers & prevention Vol. 20; no. 1; pp. 172 - 182 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Philadelphia, PA
American Association for Cancer Research
01.01.2011
|
Subjects | |
Online Access | Get full text |
ISSN | 1055-9965 1538-7755 1538-7755 |
DOI | 10.1158/1055-9965.EPI-10-0682 |
Cover
Abstract | Background: Oral human papillomavirus type-16 (HPV16) infection is a risk factor for oropharyngeal cancer. We examined oral HPV infection among healthy men.
Methods: Oral rinse/gargle specimens and questionnaire data were collected from 1,688 healthy men aged 18 to 74 (median = 31 years), from the United States, Mexico, and Brazil. HPV16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58 and 59, and noncarcinogenic HPV types were detected using Roche Linear Array.
Results: Oral HPV DNA was detected in 67 of 1,680 (4.0%, 95% CI = 3.1%–5.0%) β-globin–positive specimens; carcinogenic HPVs were detected in 1.3% (95% CI = 0.8%–2.0%; n = 22) and HPV16 was the most commonly detected carcinogenic HPV type (0.6%, 95% CI = 0.2%–1.1%; n = 10). The prevalence of oral HPV infection was similar by country except for HPV55, which had notably higher prevalence in Mexico (3.0%) than Brazil (0%) or the United States (0.2%). Oral HPV prevalence nonsignificantly increased over increasing age categories (Ptrend = 0.096). The strongest predictor of oral HPV was current tobacco use, which increased the odds 2.5-fold (95% CI = 1.4–4.4). Oral sexual behaviors were not associated with oral HPV infection.
Conclusions: Oral HPV16 infection was rare in healthy men, especially at younger ages, and was positively associated with current tobacco use.
Impact: Oral HPV appears to be about 10-fold less prevalent than infection at genital sites in men (4% vs. ∼40%, respectively). It remains unclear whether this reflects reduced exposure or if the oral region is more resistant to HPV infection compared with anogenital sites. Cancer Epidemiol Biomarkers Prev; 20(1); 172–82. ©2011 AACR. |
---|---|
AbstractList | Background: Oral human papillomavirus type-16 (HPV16) infection is a risk factor for oropharyngeal cancer. We examined oral HPV infection among healthy men.
Methods: Oral rinse/gargle specimens and questionnaire data were collected from 1,688 healthy men aged 18 to 74 (median = 31 years), from the United States, Mexico, and Brazil. HPV16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58 and 59, and noncarcinogenic HPV types were detected using Roche Linear Array.
Results: Oral HPV DNA was detected in 67 of 1,680 (4.0%, 95% CI = 3.1%–5.0%) β-globin–positive specimens; carcinogenic HPVs were detected in 1.3% (95% CI = 0.8%–2.0%; n = 22) and HPV16 was the most commonly detected carcinogenic HPV type (0.6%, 95% CI = 0.2%–1.1%; n = 10). The prevalence of oral HPV infection was similar by country except for HPV55, which had notably higher prevalence in Mexico (3.0%) than Brazil (0%) or the United States (0.2%). Oral HPV prevalence nonsignificantly increased over increasing age categories (Ptrend = 0.096). The strongest predictor of oral HPV was current tobacco use, which increased the odds 2.5-fold (95% CI = 1.4–4.4). Oral sexual behaviors were not associated with oral HPV infection.
Conclusions: Oral HPV16 infection was rare in healthy men, especially at younger ages, and was positively associated with current tobacco use.
Impact: Oral HPV appears to be about 10-fold less prevalent than infection at genital sites in men (4% vs. ∼40%, respectively). It remains unclear whether this reflects reduced exposure or if the oral region is more resistant to HPV infection compared with anogenital sites. Cancer Epidemiol Biomarkers Prev; 20(1); 172–82. ©2011 AACR. BACKGROUND: Oral human papillomavirus type-16 (HPV16) infection is a risk factor for oropharyngeal cancer. We examined oral HPV infection among healthy men. METHODS: Oral rinse/gargle specimens and questionnaire data were collected from 1,688 healthy men aged 18 to 74 (median = 31 years), from the United States, Mexico, and Brazil. HPV16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58 and 59, and noncarcinogenic HPV types were detected using Roche Linear Array. RESULTS: Oral HPV DNA was detected in 67 of 1,680 (4.0%, 95% CI = 3.1%-5.0%) beta -globin-positive specimens; carcinogenic HPVs were detected in 1.3% (95% CI = 0.8%-2.0%; n = 22) and HPV16 was the most commonly detected carcinogenic HPV type (0.6%, 95% CI = 0.2%-1.1%; n = 10). The prevalence of oral HPV infection was similar by country except for HPV55, which had notably higher prevalence in Mexico (3.0%) than Brazil (0%) or the United States (0.2%). Oral HPV prevalence nonsignificantly increased over increasing age categories (Ptrend = 0.096). The strongest predictor of oral HPV was current tobacco use, which increased the odds 2.5-fold (95% CI = 1.4-4.4). Oral sexual behaviors were not associated with oral HPV infection. CONCLUSIONS: Oral HPV16 infection was rare in healthy men, especially at younger ages, and was positively associated with current tobacco use. IMPACT: Oral HPV appears to be about 10-fold less prevalent than infection at genital sites in men (4% vs. similar to 40%, respectively). It remains unclear whether this reflects reduced exposure or if the oral region is more resistant to HPV infection compared with anogenital sites. Cancer Epidemiol Biomarkers Prev; 20(1); 172-82. [copy ]2011 AACR. Oral human papillomavirus type-16 (HPV16) infection is a risk factor for oropharyngeal cancer. We examined oral HPV infection among healthy men. Oral rinse/gargle specimens and questionnaire data were collected from 1,688 healthy men aged 18 to 74 (median = 31 years), from the United States, Mexico, and Brazil. HPV16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58 and 59, and noncarcinogenic HPV types were detected using Roche Linear Array. Oral HPV DNA was detected in 67 of 1,680 (4.0%, 95% CI = 3.1%-5.0%) β-globin-positive specimens; carcinogenic HPVs were detected in 1.3% (95% CI = 0.8%-2.0%; n = 22) and HPV16 was the most commonly detected carcinogenic HPV type (0.6%, 95% CI = 0.2%-1.1%; n = 10). The prevalence of oral HPV infection was similar by country except for HPV55, which had notably higher prevalence in Mexico (3.0%) than Brazil (0%) or the United States (0.2%). Oral HPV prevalence nonsignificantly increased over increasing age categories (P(trend) = 0.096). The strongest predictor of oral HPV was current tobacco use, which increased the odds 2.5-fold (95% CI = 1.4-4.4). Oral sexual behaviors were not associated with oral HPV infection. Oral HPV16 infection was rare in healthy men, especially at younger ages, and was positively associated with current tobacco use. Oral HPV appears to be about 10-fold less prevalent than infection at genital sites in men (4% vs. ∼40%, respectively). It remains unclear whether this reflects reduced exposure or if the oral region is more resistant to HPV infection compared with anogenital sites. Oral human papillomavirus type-16 (HPV16) infection is a risk factor for oropharyngeal cancer. We examined oral HPV infection among healthy men.BACKGROUNDOral human papillomavirus type-16 (HPV16) infection is a risk factor for oropharyngeal cancer. We examined oral HPV infection among healthy men.Oral rinse/gargle specimens and questionnaire data were collected from 1,688 healthy men aged 18 to 74 (median = 31 years), from the United States, Mexico, and Brazil. HPV16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58 and 59, and noncarcinogenic HPV types were detected using Roche Linear Array.METHODSOral rinse/gargle specimens and questionnaire data were collected from 1,688 healthy men aged 18 to 74 (median = 31 years), from the United States, Mexico, and Brazil. HPV16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58 and 59, and noncarcinogenic HPV types were detected using Roche Linear Array.Oral HPV DNA was detected in 67 of 1,680 (4.0%, 95% CI = 3.1%-5.0%) β-globin-positive specimens; carcinogenic HPVs were detected in 1.3% (95% CI = 0.8%-2.0%; n = 22) and HPV16 was the most commonly detected carcinogenic HPV type (0.6%, 95% CI = 0.2%-1.1%; n = 10). The prevalence of oral HPV infection was similar by country except for HPV55, which had notably higher prevalence in Mexico (3.0%) than Brazil (0%) or the United States (0.2%). Oral HPV prevalence nonsignificantly increased over increasing age categories (P(trend) = 0.096). The strongest predictor of oral HPV was current tobacco use, which increased the odds 2.5-fold (95% CI = 1.4-4.4). Oral sexual behaviors were not associated with oral HPV infection.RESULTSOral HPV DNA was detected in 67 of 1,680 (4.0%, 95% CI = 3.1%-5.0%) β-globin-positive specimens; carcinogenic HPVs were detected in 1.3% (95% CI = 0.8%-2.0%; n = 22) and HPV16 was the most commonly detected carcinogenic HPV type (0.6%, 95% CI = 0.2%-1.1%; n = 10). The prevalence of oral HPV infection was similar by country except for HPV55, which had notably higher prevalence in Mexico (3.0%) than Brazil (0%) or the United States (0.2%). Oral HPV prevalence nonsignificantly increased over increasing age categories (P(trend) = 0.096). The strongest predictor of oral HPV was current tobacco use, which increased the odds 2.5-fold (95% CI = 1.4-4.4). Oral sexual behaviors were not associated with oral HPV infection.Oral HPV16 infection was rare in healthy men, especially at younger ages, and was positively associated with current tobacco use.CONCLUSIONSOral HPV16 infection was rare in healthy men, especially at younger ages, and was positively associated with current tobacco use.Oral HPV appears to be about 10-fold less prevalent than infection at genital sites in men (4% vs. ∼40%, respectively). It remains unclear whether this reflects reduced exposure or if the oral region is more resistant to HPV infection compared with anogenital sites.IMPACTOral HPV appears to be about 10-fold less prevalent than infection at genital sites in men (4% vs. ∼40%, respectively). It remains unclear whether this reflects reduced exposure or if the oral region is more resistant to HPV infection compared with anogenital sites. |
Author | Smith, Danelle Papenfuss, Mary Kreimer, Aimee R. Villa, Alessandro Hildesheim, Allan Giuliano, Anna R. Abrahamsen, Martha Villa, Luisa L. Nyitray, Alan G. Lazcano-Ponce, Eduardo |
AuthorAffiliation | 1 National Cancer Institute, NIH, Bethesda, Maryland 4 Instituto Nacional de Salud Pública, Cuernavaca, México 2 H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 3 Ludwig Institute for Cancer Research, São Paulo, Brazil |
AuthorAffiliation_xml | – name: 1 National Cancer Institute, NIH, Bethesda, Maryland – name: 2 H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL – name: 4 Instituto Nacional de Salud Pública, Cuernavaca, México – name: 3 Ludwig Institute for Cancer Research, São Paulo, Brazil |
Author_xml | – sequence: 1 givenname: Aimee R. surname: Kreimer fullname: Kreimer, Aimee R. – sequence: 2 givenname: Alessandro surname: Villa fullname: Villa, Alessandro – sequence: 3 givenname: Alan G. surname: Nyitray fullname: Nyitray, Alan G. – sequence: 4 givenname: Martha surname: Abrahamsen fullname: Abrahamsen, Martha – sequence: 5 givenname: Mary surname: Papenfuss fullname: Papenfuss, Mary – sequence: 6 givenname: Danelle surname: Smith fullname: Smith, Danelle – sequence: 7 givenname: Allan surname: Hildesheim fullname: Hildesheim, Allan – sequence: 8 givenname: Luisa L. surname: Villa fullname: Villa, Luisa L. – sequence: 9 givenname: Eduardo surname: Lazcano-Ponce fullname: Lazcano-Ponce, Eduardo – sequence: 10 givenname: Anna R. surname: Giuliano fullname: Giuliano, Anna R. |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=23757458$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/21148755$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkltr3DAQhUVJaZJtf0KLXkqenOpiWRaFQgnb7EJCQpvkVcjyeFdFlraWN7D_vnKySS8veZIYfedwNDPH6CDEAAi9p-SUUlF_okSIQqlKnM6vlwUlBalq9godUcHrQkohDvL9iTlExyn9JIRIJcQbdMgoLevMHKHvN2vA841roXfRx9UOxw5fDcbjxfUdXoYO7OhiwKaPYYUNvtz60QUz1TLzw_QbD5NkAcaP6x2-hPAWve6MT_Buf87Q7bf5zdmiuLg6X559vShsjjgWsgFFWKugIrWtKK04pw1thGJEVcxIwYWsiDK2VZ0VDeVU8o6QWkoJnKmWz9CXR9_NtumhtRDGnFtvBtebYaejcfrfl-DWehXvNSdMUl5ng5O9wRB_bSGNunfJgvcmQNwmrUhZViXl6kWyZiz_hWTXGfrwd6jnNE8dz8DHPWCSNb4bTLAu_eG4FLIUUzjxyNkhpjRA94xQoqcN0NN09TRdnTdgqk4bkHWf_9NZNz7MK_fA-RfUvwGt_LRR |
CODEN | CEBPE4 |
CitedBy_id | crossref_primary_10_1016_j_oraloncology_2013_06_002 crossref_primary_10_1684_bdc_2014_1957 crossref_primary_10_1097_OLQ_0b013e31824f1c65 crossref_primary_10_1186_1471_2407_11_473 crossref_primary_10_1016_j_oraloncology_2013_06_007 crossref_primary_10_1002_osi2_1022 crossref_primary_10_1080_23744235_2017_1300319 crossref_primary_10_1016_j_ijid_2018_02_003 crossref_primary_10_1016_S1773_035X_11_71056_5 crossref_primary_10_1515_ii_2017_0113 crossref_primary_10_1002_jmv_27893 crossref_primary_10_5935_1808_8694_20130107 crossref_primary_10_1186_1472_6831_11_28 crossref_primary_10_1002_ijc_33442 crossref_primary_10_1016_j_oraloncology_2018_04_005 crossref_primary_10_1007_s10552_017_0966_z crossref_primary_10_1038_srep15637 crossref_primary_10_15446_revfacmed_v64n1_53736 crossref_primary_10_1002_lary_25767 crossref_primary_10_1002_ijc_33732 crossref_primary_10_3390_pharmaceutics11070302 crossref_primary_10_1111_jop_12291 crossref_primary_10_1002_cncr_29111 crossref_primary_10_1200_JCO_2014_55_1341 crossref_primary_10_1158_1940_6207_CAPR_13_0081 crossref_primary_10_1016_j_eururo_2012_06_045 crossref_primary_10_1002_ijc_29082 crossref_primary_10_1002_lio2_316 crossref_primary_10_1097_QAD_0b013e328362395c crossref_primary_10_1007_s12105_012_0377_0 crossref_primary_10_3390_jcm11071935 crossref_primary_10_1002_lary_26175 crossref_primary_10_1016_j_oooo_2015_04_004 crossref_primary_10_1016_j_vaccine_2019_08_058 crossref_primary_10_3390_ijerph19127213 crossref_primary_10_3390_pathogens10111411 crossref_primary_10_1590_1414_431X20132703 crossref_primary_10_1016_j_pvr_2018_03_003 crossref_primary_10_1016_j_otc_2012_04_003 crossref_primary_10_1128_JCM_05933_11 crossref_primary_10_1071_SH16155 crossref_primary_10_1002_jmv_24555 crossref_primary_10_1093_infdis_jix245 crossref_primary_10_1158_1055_9965_EPI_14_0386 crossref_primary_10_1158_1940_6207_CAPR_11_0379 crossref_primary_10_1097_OLQ_0b013e31827e87bd crossref_primary_10_1016_j_meegid_2020_104283 crossref_primary_10_14219_jada_archive_2012_0194 crossref_primary_10_1186_1471_2334_14_43 crossref_primary_10_1016_j_bjid_2013_07_013 crossref_primary_10_1158_1940_6207_CAPR_23_0317 crossref_primary_10_1177_1559827615569707 crossref_primary_10_35509_01239015_30 crossref_primary_10_1016_j_vaccine_2021_07_069 crossref_primary_10_1097_PAT_0000000000000068 crossref_primary_10_1002_ijc_28201 crossref_primary_10_1007_s10096_013_1938_1 crossref_primary_10_1371_journal_pone_0143698 crossref_primary_10_1093_aje_kwu247 crossref_primary_10_1002_cam4_5686 crossref_primary_10_1097_CCO_0b013e32836242b4 crossref_primary_10_1016_j_virol_2017_07_006 crossref_primary_10_1016_j_virol_2016_04_031 crossref_primary_10_1097_OLQ_0000000000000264 crossref_primary_10_1111_j_1601_0825_2011_01892_x crossref_primary_10_1002_jmv_26356 crossref_primary_10_1038_s41379_022_01024_8 crossref_primary_10_1371_journal_pone_0157976 crossref_primary_10_1016_j_epidem_2017_08_001 crossref_primary_10_1128_jcm_01403_22 crossref_primary_10_1016_j_oooo_2013_06_019 crossref_primary_10_1371_journal_pone_0091761 crossref_primary_10_1002_dc_22837 crossref_primary_10_1002_ijc_32713 crossref_primary_10_1016_j_jim_2013_10_005 crossref_primary_10_1099_jgv_0_000727 crossref_primary_10_1158_1940_6207_CAPR_14_0296 crossref_primary_10_1016_j_otoeng_2016_04_014 crossref_primary_10_1097_01_OLQ_0000430798_61475_08 crossref_primary_10_1016_j_otorri_2016_04_003 crossref_primary_10_3390_cancers6031705 crossref_primary_10_1158_1055_9965_EPI_14_0084 crossref_primary_10_1002_cncr_30312 crossref_primary_10_1111_jop_13474 crossref_primary_10_1097_OLQ_0000000000001802 crossref_primary_10_1097_OLQ_0b013e318269d098 crossref_primary_10_1111_odi_12365 crossref_primary_10_1007_s10096_014_2061_7 crossref_primary_10_1016_j_otpol_2014_05_004 crossref_primary_10_1080_21505594_2014_999570 crossref_primary_10_1111_1469_0691_12523 crossref_primary_10_1002_ijc_29827 crossref_primary_10_1097_OLQ_0000000000000159 crossref_primary_10_12998_wjcc_v2_i6_172 crossref_primary_10_1038_s41564_024_01824_5 crossref_primary_10_1371_journal_pone_0165847 crossref_primary_10_1016_j_oraloncology_2020_104669 crossref_primary_10_1158_1055_9965_EPI_11_0734 crossref_primary_10_1136_sextrans_2020_054428 crossref_primary_10_1111_jicd_12313 crossref_primary_10_1128_JCM_00286_14 crossref_primary_10_1016_j_oraloncology_2013_09_003 crossref_primary_10_1016_j_pvr_2015_06_007 crossref_primary_10_1016_j_vaccine_2019_03_034 crossref_primary_10_1016_j_cct_2021_106592 crossref_primary_10_1007_s13193_016_0559_4 crossref_primary_10_1186_1472_6831_12_43 crossref_primary_10_1097_OLQ_0000000000000563 crossref_primary_10_1002_jmv_26130 crossref_primary_10_3390_diagnostics11122180 crossref_primary_10_1016_j_oraloncology_2017_01_001 crossref_primary_10_1016_j_amjoto_2019_02_006 crossref_primary_10_1002_ijc_34517 crossref_primary_10_1007_s00784_019_03048_y crossref_primary_10_1186_1472_6831_14_7 crossref_primary_10_1007_s12105_023_01597_z crossref_primary_10_1080_23744235_2020_1811373 crossref_primary_10_1158_1055_9965_EPI_23_0626 crossref_primary_10_3390_cancers17030344 crossref_primary_10_1016_j_vaccine_2018_02_079 crossref_primary_10_1111_odi_13510 crossref_primary_10_5812_ijhrba_18053 crossref_primary_10_1002_ijc_32570 crossref_primary_10_1016_j_medcli_2023_04_032 crossref_primary_10_3390_cancers6031691 crossref_primary_10_1002_cncr_32152 crossref_primary_10_1016_S0140_6736_13_60809_0 crossref_primary_10_1016_j_canep_2011_12_007 crossref_primary_10_1111_ors_12152 crossref_primary_10_18632_oncotarget_27436 crossref_primary_10_1016_j_prp_2018_08_032 crossref_primary_10_1016_j_medcle_2023_04_033 crossref_primary_10_1016_j_oooo_2019_12_005 crossref_primary_10_1515_hsz_2017_0105 crossref_primary_10_1136_sextrans_2014_051955 crossref_primary_10_1016_j_vaccine_2012_05_070 crossref_primary_10_1007_s00106_012_2552_8 crossref_primary_10_1016_j_hoc_2024_04_001 crossref_primary_10_1093_infdis_jit369 crossref_primary_10_1093_cid_ciaa1701 crossref_primary_10_1111_odi_12550 crossref_primary_10_1007_s00106_013_2676_5 crossref_primary_10_5937_bjdm2301038A crossref_primary_10_1016_j_pvr_2020_100199 |
Cites_doi | 10.1097/00007435-199904001-00002 10.1097/OLQ.0b013e3181c94a3b 10.1086/514052 10.1158/1055-9965.EPI-05-0460 10.1128/JCM.36.10.3020-3027.1998 10.1056/NEJMoa065497 10.1086/597755 10.1158/1055-9965.EPI-04-0551 10.1158/1055-9965.EPI-09-0983 10.1016/S1473-3099(07)70158-5 10.1158/1055-9965.EPI-05-0983 10.1093/oxfordjournals.jncimonographs.a003477 10.1158/1055-9965.EPI-08-0151 10.1016/j.virol.2005.04.002 10.1093/aje/kwp225 10.1093/jnci/94.18.1406 10.1086/381504 10.1002/cncr.22963 10.1016/S1470-2045(09)70096-8 10.1111/j.1600-0714.2007.00556.x 10.1002/ijc.21731 10.1097/INF.0b013e318124a4ae 10.1002/ijc.24097 10.1128/JCM.38.1.357-361.2000 10.1093/jnci/djn025 10.1023/A:1020668232219 10.1128/JCM.43.11.5526-5535.2005 |
ContentType | Journal Article |
Copyright | 2015 INIST-CNRS 2011 AACR. Copyright © 2010 American Association for Cancer Research 2010 |
Copyright_xml | – notice: 2015 INIST-CNRS – notice: 2011 AACR. – notice: Copyright © 2010 American Association for Cancer Research 2010 |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 7U1 7U9 C1K H94 5PM |
DOI | 10.1158/1055-9965.EPI-10-0682 |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic Risk Abstracts Virology and AIDS Abstracts Environmental Sciences and Pollution Management AIDS and Cancer Research Abstracts PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic Risk Abstracts AIDS and Cancer Research Abstracts Virology and AIDS Abstracts Environmental Sciences and Pollution Management |
DatabaseTitleList | CrossRef Risk Abstracts MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1538-7755 |
EndPage | 182 |
ExternalDocumentID | PMC3027138 21148755 23757458 10_1158_1055_9965_EPI_10_0682 |
Genre | Journal Article Research Support, N.I.H., Intramural Research Support, N.I.H., Extramural |
GeographicLocations | Brazil United States Mexico USA |
GeographicLocations_xml | – name: Mexico – name: United States – name: Brazil – name: USA |
GrantInformation_xml | – fundername: NCI NIH HHS grantid: R01CA098803 – fundername: NCI NIH HHS grantid: R01 CA098803 – fundername: Intramural NIH HHS grantid: ZIA CP010209 – fundername: NCI NIH HHS grantid: P30 CA076292 |
GroupedDBID | --- 18M 29B 2FS 2WC 34G 39C 53G 5GY 5VS 6J9 AAFWJ AAYXX ABOCM ACPRK ADBBV ADCOW AENEX AFHIN AFRAH ALMA_UNASSIGNED_HOLDINGS BR6 BTFSW C1A CITATION CS3 DIK DU5 E3Z EBS EJD F5P FRP H13 IH2 KQ8 L7B OK1 P2P PQQKQ QTD RCR RHI SJN UDS W8F WOQ .55 3O- AI. H~9 IQODW VH1 WHG X7M ZXP CGR CUY CVF ECM EIF NPM 7X8 7U1 7U9 C1K H94 5PM |
ID | FETCH-LOGICAL-c538t-7be902d9e608c6116331b1b5920962a75357609acd9fc5b13173f008777e329d3 |
ISSN | 1055-9965 1538-7755 |
IngestDate | Thu Aug 21 14:31:15 EDT 2025 Fri Jul 11 10:55:19 EDT 2025 Thu Jul 10 18:23:14 EDT 2025 Mon Jul 21 06:06:50 EDT 2025 Mon Jul 21 09:13:11 EDT 2025 Tue Jul 01 04:31:21 EDT 2025 Thu Apr 24 23:00:25 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Human Healthy subject Oral administration Male Papovaviridae Epidemiology Papillomavirus Virus Infection Human papillomavirus Cancerology Adult Public health |
Language | English |
License | CC BY 4.0 2011 AACR. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c538t-7be902d9e608c6116331b1b5920962a75357609acd9fc5b13173f008777e329d3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 |
OpenAccessLink | https://aacrjournals.org/cebp/article-pdf/20/1/172/2272672/172.pdf |
PMID | 21148755 |
PQID | 822902071 |
PQPubID | 23479 |
PageCount | 11 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_3027138 proquest_miscellaneous_904464139 proquest_miscellaneous_822902071 pubmed_primary_21148755 pascalfrancis_primary_23757458 crossref_primary_10_1158_1055_9965_EPI_10_0682 crossref_citationtrail_10_1158_1055_9965_EPI_10_0682 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2011-01-01 |
PublicationDateYYYYMMDD | 2011-01-01 |
PublicationDate_xml | – month: 01 year: 2011 text: 2011-01-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Philadelphia, PA |
PublicationPlace_xml | – name: Philadelphia, PA – name: United States |
PublicationTitle | Cancer epidemiology, biomarkers & prevention |
PublicationTitleAlternate | Cancer Epidemiol Biomarkers Prev |
PublicationYear | 2011 |
Publisher | American Association for Cancer Research |
Publisher_xml | – name: American Association for Cancer Research |
References | Kreimer (2022060919565960600_bib5) 2010; 37 D'Souza (2022060919565960600_bib4) 2007; 356 Castellsague (2022060919565960600_bib18) 1997; 176 Montaldo (2022060919565960600_bib7) 2007; 36 Bouvard (2022060919565960600_bib2) 2009; 10 Smith (2022060919565960600_bib8) 2007; 26 Nyitray (2022060919565960600_bib14) 2010 Hernandez (2022060919565960600_bib15) 2005; 14 Giuliano (2022060919565960600_bib9) 2008; 17 Gravitt (2022060919565960600_bib11) 1998; 36 Proia (2022060919565960600_bib21) 2006; 15 Vaccarella (2022060919565960600_bib28) 2010; 19 De Sanjose (2022060919565960600_bib13) 2007; 7 Castle (2022060919565960600_bib23) 2002; 94 Franceschi (2022060919565960600_bib17) 2002 Schiffman (2022060919565960600_bib26) 2005; 337 Cates (2022060919565960600_bib29) 1999; 26 D'Souza (2022060919565960600_bib10) 2005; 43 D'Souza (2022060919565960600_bib20) 2009; 199 Giuliano (2022060919565960600_bib24) 2002; 13 Sturgis (2022060919565960600_bib30) 2007; 110 Gravitt (2022060919565960600_bib12) 2000; 38 Parkin (2022060919565960600_bib1) 2006; 118 Nyitray (2022060919565960600_bib25) 2009; 170 Kreimer (2022060919565960600_bib6) 2004; 189 Giuliano (2022060919565960600_bib16) 2009; 124 Chaturvedi (2022060919565960600_bib27) 2010 Gillison (2022060919565960600_bib19) 2008; 100 Castellsague (2022060919565960600_bib22) 2003 Kreimer (2022060919565960600_bib3) 2005; 14 |
References_xml | – volume: 26 start-page: S2 year: 1999 ident: 2022060919565960600_bib29 article-title: Estimates of the incidence and prevalence of sexually transmitted diseases in the United States. American Social Health Association Panel publication-title: Sex Transm Dis doi: 10.1097/00007435-199904001-00002 – volume: 37 start-page: 386 year: 2010 ident: 2022060919565960600_bib5 article-title: Oral human papillomavirus in healthy individuals: a systematic review of the literature publication-title: Sex Transm Dis doi: 10.1097/OLQ.0b013e3181c94a3b – volume: 176 start-page: 353 year: 1997 ident: 2022060919565960600_bib18 article-title: Prevalence of penile human papillomavirus DNA in husbands of women with and without cervical neoplasia: a study in Spain and Colombia publication-title: J Infect Dis doi: 10.1086/514052 – volume: 14 start-page: 2550 year: 2005 ident: 2022060919565960600_bib15 article-title: Anal human papillomavirus infection in women and its relationship with cervical infection publication-title: Cancer Epidemiol Biomarkers Prev doi: 10.1158/1055-9965.EPI-05-0460 – year: 2010 ident: 2022060919565960600_bib27 article-title: Oral and anal HPV infection among HIV-infected men and women – volume: 36 start-page: 3020 year: 1998 ident: 2022060919565960600_bib11 article-title: Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method publication-title: J Clin Microbiol doi: 10.1128/JCM.36.10.3020-3027.1998 – volume: 356 start-page: 1944 year: 2007 ident: 2022060919565960600_bib4 article-title: Case-control study of human papillomavirus and oropharyngeal cancer publication-title: N Engl J Med doi: 10.1056/NEJMoa065497 – start-page: 1498 volume-title: J Infect Dis year: 2010 ident: 2022060919565960600_bib14 article-title: Prevalence of and risk factors for anal human papillomavirus infection in men who have sex with women: a cross-national study – volume: 199 start-page: 1263 year: 2009 ident: 2022060919565960600_bib20 article-title: Oral sexual behaviors associated with prevalent oral human papillomavirus infection publication-title: J Infect Dis doi: 10.1086/597755 – start-page: 705 volume-title: Br J Cancer year: 2002 ident: 2022060919565960600_bib17 article-title: Prevalence and determinants of human papillomavirus genital infection in men – volume: 14 start-page: 467 year: 2005 ident: 2022060919565960600_bib3 article-title: Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review publication-title: Cancer Epidemiol Biomarkers Prev doi: 10.1158/1055-9965.EPI-04-0551 – volume: 19 start-page: 503 year: 2010 ident: 2022060919565960600_bib28 article-title: Concurrent infection with multiple human papillomavirus types: pooled analysis of the IARC HPV Prevalence Surveys publication-title: Cancer Epidemiol Biomarkers Prev doi: 10.1158/1055-9965.EPI-09-0983 – volume: 7 start-page: 453 year: 2007 ident: 2022060919565960600_bib13 article-title: Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis publication-title: Lancet Infect Dis doi: 10.1016/S1473-3099(07)70158-5 – volume: 15 start-page: 1061 year: 2006 ident: 2022060919565960600_bib21 article-title: Smoking and smokeless tobacco-associated human buccal cell mutations and their association with oral cancer—a review publication-title: Cancer Epidemiol Biomarkers Prev doi: 10.1158/1055-9965.EPI-05-0983 – start-page: 20 year: 2003 ident: 2022060919565960600_bib22 article-title: Cofactors in human papillomavirus carcinogenesis–role of parity, oral contraceptives, and tobacco smoking publication-title: J Natl Cancer Inst Monogr doi: 10.1093/oxfordjournals.jncimonographs.a003477 – volume: 17 start-page: 2036 year: 2008 ident: 2022060919565960600_bib9 article-title: The human papillomavirus infection in men study: human papillomavirus prevalence and type distribution among men residing in Brazil, Mexico, and the United States publication-title: Cancer Epidemiol Biomarkers Prev doi: 10.1158/1055-9965.EPI-08-0151 – volume: 337 start-page: 76 year: 2005 ident: 2022060919565960600_bib26 article-title: The carcinogenicity of human papillomavirus types reflects viral evolution publication-title: Virology doi: 10.1016/j.virol.2005.04.002 – volume: 170 start-page: 965 year: 2009 ident: 2022060919565960600_bib25 article-title: Test-retest reliability of a sexual behavior interview for men residing in Brazil, Mexico, and the United States: the HPV in Men (HIM) Study publication-title: Am J Epidemiol doi: 10.1093/aje/kwp225 – volume: 94 start-page: 1406 year: 2002 ident: 2022060919565960600_bib23 article-title: A prospective study of high-grade cervical neoplasia risk among human papillomavirus-infected women publication-title: J Natl Cancer Inst doi: 10.1093/jnci/94.18.1406 – volume: 189 start-page: 686 year: 2004 ident: 2022060919565960600_bib6 article-title: Oral human papillomavirus infection in adults is associated with sexual behavior and HIV serostatus publication-title: J Infect Dis doi: 10.1086/381504 – volume: 110 start-page: 1429 year: 2007 ident: 2022060919565960600_bib30 article-title: Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers? publication-title: Cancer doi: 10.1002/cncr.22963 – volume: 10 start-page: 321 year: 2009 ident: 2022060919565960600_bib2 article-title: A review of human carcinogens–Part B: biological agents publication-title: Lancet Oncol doi: 10.1016/S1470-2045(09)70096-8 – volume: 36 start-page: 482 year: 2007 ident: 2022060919565960600_bib7 article-title: Detection and genotyping of human papillomavirus DNA in samples from healthy Sardinian patients: a preliminary study publication-title: J Oral Pathol Med doi: 10.1111/j.1600-0714.2007.00556.x – volume: 118 start-page: 3030 year: 2006 ident: 2022060919565960600_bib1 article-title: The global health burden of infection-associated cancers in the year 2002 publication-title: Int J Cancer doi: 10.1002/ijc.21731 – volume: 26 start-page: 836 year: 2007 ident: 2022060919565960600_bib8 article-title: Prevalence of human papillomavirus in the oral cavity/oropharynx in a large population of children and adolescents publication-title: Pediatr Infect Dis J doi: 10.1097/INF.0b013e318124a4ae – volume: 124 start-page: 1251 year: 2009 ident: 2022060919565960600_bib16 article-title: Circumcision and sexual behavior: factors independently associated with human papillomavirus detection among men in the HIM study publication-title: Int J Cancer doi: 10.1002/ijc.24097 – volume: 38 start-page: 357 year: 2000 ident: 2022060919565960600_bib12 article-title: Improved amplification of genital human papillomaviruses publication-title: J Clin Microbiol doi: 10.1128/JCM.38.1.357-361.2000 – volume: 100 start-page: 407 year: 2008 ident: 2022060919565960600_bib19 article-title: Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers publication-title: J Natl Cancer Inst doi: 10.1093/jnci/djn025 – volume: 13 start-page: 839 year: 2002 ident: 2022060919565960600_bib24 article-title: Clearance of oncogenic human papillomavirus (HPV) infection: effect of smoking (United States) publication-title: Cancer Causes Control doi: 10.1023/A:1020668232219 – volume: 43 start-page: 5526 year: 2005 ident: 2022060919565960600_bib10 article-title: Analysis of the effect of DNA purification on detection of human papillomavirus in oral rinse samples by PCR publication-title: J Clin Microbiol doi: 10.1128/JCM.43.11.5526-5535.2005 |
SSID | ssj0007955 |
Score | 2.425782 |
Snippet | Background: Oral human papillomavirus type-16 (HPV16) infection is a risk factor for oropharyngeal cancer. We examined oral HPV infection among healthy men.... Oral human papillomavirus type-16 (HPV16) infection is a risk factor for oropharyngeal cancer. We examined oral HPV infection among healthy men. Oral... Oral human papillomavirus type-16 (HPV16) infection is a risk factor for oropharyngeal cancer. We examined oral HPV infection among healthy men.BACKGROUNDOral... BACKGROUND: Oral human papillomavirus type-16 (HPV16) infection is a risk factor for oropharyngeal cancer. We examined oral HPV infection among healthy men.... |
SourceID | pubmedcentral proquest pubmed pascalfrancis crossref |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 172 |
SubjectTerms | Adolescent Adult Age Aged Anogenital Bioindicators Biological and medical sciences biomarkers Brazil - epidemiology Cancer Carcinogenicity Cohort Studies Data processing DNA Epidemiology Human papillomavirus Human papillomavirus 16 Human papillomavirus 16 - isolation & purification Humans Infection Inventories Male males Medical sciences Mexico - epidemiology Middle Aged Mouth - virology Mouth Diseases - epidemiology Mouth Diseases - virology oropharyngeal cancer Oropharyngeal Neoplasms - epidemiology Oropharyngeal Neoplasms - virology Papillomavirus Infections - epidemiology Papillomavirus Infections - virology Prevalence Risk Factors Sexual behavior Smoking - epidemiology Tobacco Tumors United States - epidemiology Young Adult |
Title | The Epidemiology of Oral HPV Infection among a Multinational Sample of Healthy Men |
URI | https://www.ncbi.nlm.nih.gov/pubmed/21148755 https://www.proquest.com/docview/822902071 https://www.proquest.com/docview/904464139 https://pubmed.ncbi.nlm.nih.gov/PMC3027138 |
Volume | 20 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 1538-7755 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0007955 issn: 1055-9965 databaseCode: KQ8 dateStart: 19911101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 1538-7755 dateEnd: 20240930 omitProxy: true ssIdentifier: ssj0007955 issn: 1055-9965 databaseCode: DIK dateStart: 19910101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELbKIiEkhHgu5bHygT2tsiRO7MTHamlVYF9Au-otchJHWwmlpY9D-Qf8a2ZsN03ZogUuUZT4IXk-2-PxzHyEvM1UwuIgKD2mtfAiwZSXlCz2RAGaHKgPkvkYjXx2LvrD6OOIj1qtnw2vpeUiO85_7Iwr-R-pwjeQK0bJ_oNk60bhA7yDfOEJEobnX8u4u6F4NZflFxhx37-8gplv3awqRyikjkywbW39-6owMbAx5BsfsBV6uDZ11RMExOxINzpAgWDAPvr0zOYGNlOXA6pxnT_TY8fJ0oEXvfFJvEKKIxdWM58rzJVQG6NX48VMrexPWHNqyq9OZmK5naEIsx5cq6apwgTsrU0VdnX1OffggMWbyy_zb8DMrqWB5fRx23JgOYpurvg8McYH1zKUHhtfO5GwzRa3vtY_v0h7w9PTdNAdDQ7D3vS7h_RjeE1_GL63-LhD7rJYCCTD-PR5k3g-loZAt-7HBYNB7-929r2l5jyYqjnMuNJSpew6y_zuktvQcQaPyEN3OKEdi7THpKWrJ-TemXO_eEq-AOBoE3B0UlIEHAXA0Rpw1ACOKroFOGoBh1Uc4CgA7hkZ9rqDk77nSDm8HPbGhRdnWvqskFr4SS4CUOfDIAsyDpNawkyH0y-cYH2p8kKWOc8C0E_D0jdpJ3XIZBE-J3vVpNIvCE0SGYdFmYdK6ygrlFSw5flKFDoSoGeKNonWY5jmLmM9Eqd8S83JlScpDn2KQ592Lz_gVxz6Njmuq01typbbKhxsCaiuxcKYxxFP2oSuJZbC6otXaqrSk-U8NXQJDNT0PxeR6DIBqqJsk30r4037aIyIOW-TeEv6dQHM_b79pxpfmxzw6G4QhMnL27t9Re5v5uJrsreYLfUbUKQX2YGB-C9Wx8ba |
linkProvider | Colorado Alliance of Research Libraries |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Epidemiology+of+Oral+HPV+Infection+among+a+Multinational+Sample+of+Healthy+Men&rft.jtitle=Cancer+epidemiology%2C+biomarkers+%26+prevention&rft.au=Kreimer%2C+Aimee+R&rft.au=Villa%2C+Alessandro&rft.au=Nyitray%2C+Alan+G&rft.au=Abrahamsen%2C+Martha&rft.date=2011-01-01&rft.issn=1055-9965&rft.volume=20&rft.issue=1&rft.spage=172&rft.epage=182&rft_id=info:doi/10.1158%2F1055-9965.epi-10-0682&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1055-9965&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1055-9965&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1055-9965&client=summon |